Robert Millonig, Ph.D., Deepa Shiwcharan Pharm.D. Companies interested in researching, developing, and commercializing pharmaceutical compounds should be aware of not only strategies for patenting the ...
TOKYO--(BUSINESS WIRE)--Rigaku Corporation, a global solution partner in X-ray analytical systems and a group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; ...
Aden Carter is a contributor for XDA with a focus on gaming. He has spent the last five years guiding players through their favorite games and offering his opinions on the biggest gaming topics. When ...
Hosted on MSN
Scientists redesign common deworming drug to kill cancer cells... and it could even prevent the deadly disease
What is being hailed as a 'cancer treatment breakthrough' comes not from a brand-new experimental drug, but from a 40-year-old medicine used to treat worms. Researchers from Johns Hopkins University ...
Polymorphs are not mythical, chimeric beasts—they are substances with identical chemical compositions but differing crystal structures that also exhibit different physical and chemical properties.
Researchers explored a colloidal crystal model to produce specific polymorphs, required for use in materials science and pharmaceuticals. Polymorphs are not mythical, chimeric beasts -- they are ...
The continued development of novel drugs, proteins, and advanced materials strongly rely on our ability to self-assemble molecules in solids with the most suitable structure (polymorph) in order to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results